Skip to Content

What type of drug is Verzenio?

Medically reviewed by Last updated on Oct 28, 2019.

Official Answer


Verzenio is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4 and 6 (kinase inhibitor) used as a breast cancer treatment.

Verzenio (abemaciclib) is FDA-approved to be used in 2 patient populations: either with fulvestrant (Faslodex) in patients with HR-positive, HER2-negative advanced or metastatic breast cancer that progressed after endocrine therapy; or as monotherapy for patients who previously received endocrine therapy and chemotherapy.

Related Medical Questions

Drug Information

Related Support Groups